Hepcidin levels and gastric cancer risk in the EPIC-EurGast study.
Jakszyn P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, Tous M, Arija V, Cross A, Bueno-de-Mesquita HBA, Weiderpass E, Kühn T, Kaaks R, Sjöberg K, Ohlsson B, Tumino R, Palli D, Ricceri F, Fasanelli F, Krogh V, Mattiello A, Jenab M, Gunter M, Perez-Cornago A, Khaw KT, Tjønneland A, Olsen A, Overvad K, Trichopoulou A, Peppa E, Vasilopoulou E, Boeing H, Sánchez-Cantalejo E, Huerta JM, Dorronsoro M, Barricarte A, Quirós JM, Peeters PH, Agudo A.
Jakszyn P, et al. Among authors: peeters ph.
Int J Cancer. 2017 Sep 1;141(5):945-951. doi: 10.1002/ijc.30797. Epub 2017 Jun 21.
Int J Cancer. 2017.
PMID: 28543377
Free article.